CD133+ cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD133+ cell therapy, covering 2010-01-15 to 2010-01-15. Get the full timeline:
Most recent: Clinical Trial Update: CD133+ Cell Therapy for Refractory Coronary Heart Disease [Phase 1, Phase 2]